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Abstract Lysosomal/phagosomal membranes of mammalian 
cells are coated by highly conserved glycoproteins (lamps) that 
are thought to protect the membranes from degradation. 
Interestingly, we identified an amino acid sequence in human 
lamp-1 characteristic of a cleavage site for the Neisseria 
gonorrhoeae IgAl protease. Furthermore, gonococci are detected 
in h-lamp-1-positive vacuoles after their uptake by professional 
phagocytes and epithelial cells. Here we demonstrate cleavage of 
glycosylated h-lamp-1 by the secreted gonococcal IgAl protease. 
The cleavage was observed with h-lamp-1 purified from epithelial 
cells but not from professional phagocytes. The biological role of 
lamp-1 cleavage by the gonococcal protease is discussed. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The genus Neisseria encompasses Gram-negative diplococ-
cal bacteria that successfully colonise human mucosal tissues. 
Although most of them live as harmless commensals, two 
species, Neisseria gonorrhoeae and N. meningitidis, are the 
disease causing agents of gonorrhoea and bacterial meningitis, 
respectively [1]. One of the key features that distinguish patho-
genic from non-pathogenic Neisseria is the secretion of an 
IgAl-specific serine protease (IgAl protease) by gonococci 
and meningococci [2,3]. Despite the fact that the secretion 
of this protease seems not to be crucial for the initial coloni-
sation of the urogenital mucosa and it appears not to be 
required for the adherence and the invasion of epithelial cells 
by N. gonorrhoeae in vitro [4], this enzyme apparently confers 
a selective advantage in vivo [5,6]. 
Amongst different clinical isolates of N. gonorrhoeae and N. 
meningitidis, two subtypes of the protease have been found [7]. 
Both IgAl protease forms possess a very similar proline-rich 
consensus cleavage sequence within the hinge region of human 
IgAl that is deleted in IgA2 (see Fig. 1). In addition to human 
IgAl, this consensus sequence is detectable in several other 
human proteins, most of them cell surface proteins like CD8 
where it was shown to be cleaved in a heterologous protein 
backbone [10,11]. Other potential target molecules, like syn-
aptobrevin II, are restricted to defined intracellular compart-
ments that may not naturally be accessible by gonococci [12]. 
Even though at first sight it seems unlikely that the IgAl 
protease interacts with intracellular substrates, this bacterial 
enzyme could act within infected cells: pathogenic Neisseria 
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are known to invade different cell types in vitro and in vivo, 
where they could come into intimate contact with intracellular 
proteins. For example, the co-localisation between internal-
ised bacteria and phagosomal proteins has already been docu-
mented for a long list of intracellular microorganisms [13-15]. 
In this paper we show that intracellular N. gonorrhoeae re-
sides in the same compartment as the human lysosome/late 
endosome-associated membrane protein 1 (h-lamp-1) and that 
this membrane protein contains the consensus sequence for 
cleavage by the gonococcal IgAl protease. In addition, we 
demonstrate that the secreted enzyme can be active in an 
acidic phagosomal micro-environment and that the IgAl pro-
tease is capable of cleaving glycosylated h-lamp-1. 
2. Materials and methods 
2.1. Cells and culture 
Chang human conjunctiva cells (ATCC CCL20.2) and RT112 hu-
man bladder carcinoma cells [16] were cultured as monolayers in 
DMEM medium supplemented with 10% fetal calf serum (FCS) at 
37°C in 5% CO2. The human myelomonocytic cell line JOSK-M and 
myelocytic HL60 cells, obtained from the German Collection for Mi-
croorganisms, Braunschweig (DSM ACC30 and DSM ACC3), were 
grown as suspensions in RPMI 1640 (Gibco BRL, Paisley, UK) sup-
plemented with 10% FCS (Boehringer Mannheim, Germany), 2 mM 
L-glutamine at 37°C, 5% C02. Cells were subcultured every 3^1 days. 
Prior to infection with gonococci, HL60 cells were differentiated in 
vitro by adding DMSO to a final concentration of 1.25% to the 
culture medium and incubating the cells for 5-7 days. Viability was 
determined prior to infection using trypan blue staining and in all 
cases was > 90%o. 
2.2. Bacteria 
The gonococcal variant MS11-N139 (B2.1; P" Opa30
+) [17] is the 
progenitor of the strains used in this work. Strain N303 expressing 
Opaso and strain N309 expressing Opas2 have been described [18]. The 
construction of the IgAl protease-negative JV. gonorrhoeae MS11 ex-
pressing Opaso, i.e. N876, was accomplished by transformation of 
strain N303 with pRB2 harbouring a kanamycin resistance cassette 
in the Bgñ\ site of the IgAl protease [19]. The successful knock-out of 
IgAl protease expression and secretion was tested by immunoblotting 
of total bacterial lysates and culture supernatants (data not shown). 
All gonococci were grown on GC agar (Gibco BRL) supplemented 
with vitamins and corresponding antibiotics at 37°C under 5% CO2 
and subcultured daily. 
2.3. Infection with gonococci and gentamicin assay 
For infection, bacteria were taken from plates, suspended in PBS 
containing 1 mM Ca2+ and 1 mM Mg2+ (PBS+) and washed by 
centrifugation at 500 X g for 5 min. The optical density at 550 nm 
was determined in a Hach spectrophotometer (Flach, Coveland, 
CO) and gonococci expressing Opa,,2 or Opaso were added to sus-
pended HL60 cells or to Chang cells growing on glass coverslips in 
24 well plates (Nunc, Roskilde, Denmark) at a ratio of 30 bacteria per 
cell to start the infection. In the case of HL60 cells, non-ingested 
gonococci were separated from the cells 2 h after the start of the 
infection by repeated centrifugation at 150Xg for 5 min and washing 
with PBS+. Cells were centrifuged on glass coverslips in 24 well plates 
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and fixed with 3% paraformaldehyde. In the case of Chang cells, non-
invasive bacteria were separated from cells 4 h after the start of the 
infection by repeated washing with PBS+ and the cells were fixed in 
3% paraformaldehyde for immunofluorescence staining. 
For the gentamicin assay, Chang cells or RT112 cells were cultured 
in 24 well plates without coverslips, 1 X107 bacteria of strains N303 or 
N876 were added to 2X 105 target cells in DMEM supplemented with 
10% FCS and 1 U benzonase (Boehringer Mannheim, Germany) and 
the infection was allowed to proceed for 6 h (Chang cells) or 12 h 
(RT112 cells). Samples were washed three times with PBS+ and in-
cubated for 1 h in DMEM, 10% FCS and 50 ug/ml gentamicin. After 
three washes with PBS+ the cells were lysed with 1% saponin in PBS+ 
for 10 min at 37°C and appropriate dilutions of the suspensions were 
plated on GC agar to determine the colony forming units. 
2.4. Immunofluorescence staining 
Cells were fixed on glass coverslips for 30 min in 3% paraformal-
dehyde in PBS+ at room temperature. After three washes with PBS+, 
cells were incubated for 5 min in PBS+, 10%> FCS, 0.2% saponin in 
order to permeabilise the cells and block non-specific binding sites. 
Suitable dilutions of polyclonal rabbit a-N. gonorrhoeae MS11 
(1:200; AK92) and monoclonal mouse oc-h-lamp-1 (1:50; clone 
H4A3; obtained from DSHB, University of Iowa) were added in 
PBS+, 10% FCS, 0.2%) saponin for 1 h at room temperature. Samples 
were washed twice with PBS+, blocked again for 5 min and incubated 
with FITC-conjugated goat a-rabbit and TexasRed-conjugated goat 
oc-mouse antibodies (Sigma ImmunoChemicals, St. Louis, MO) for 45 
min at room temperature. After three washes with PBS+, coverslips 
were mounted in glycerol medium (Sigma ImmunoChemicals), sealed 
with nail polish, and viewed with a Leica TCS 4D confocal laser 
scanning microscope (Leica Lasertechnik, Heidelberg, Germany) 
equipped with an argon/krypton mixed gas laser. Images were taken 
serially using appropriate excitation and emission filters for the used 
fluorescent dyes. The corresponding images were digitally processed 
with Photoshop 3.0 (Adobe Systems, Mountain View, CA). 
2.5. Preparation of recombinant IgAl protease and demonstration of 
enzyme activity 
IgAl protease of N. gonorrhoeae MS11 was prepared as described 
[10]. 2 ug of immunoglobulin Al isolated from human sputum (Sigma 
Chemicals) was incubated with 2 ul of the purified recombinant IgAl 
protease (50 ng/ul) in a total volume of 30 ul for 1 h at 37°C using 
different buffers: 50 mM sodium citrate, 10 mM NaCl adjusted to pH 
4.5 or 5, or 50 mM sodium phosphate, 10 mM NaCl adjusted to pH 
6, 6.5, 7 or 7.5. The reactions were stopped by the addition of 7 ul 
5XSDS sample buffer, 5%o ß-mercaptoethanol and the proteins were 
separated by SDS electrophoresis on 12.5% polyacrylamide gels. Pro-
tein bands were visualised by silver staining. 
2.6. Immunoprecipitation of h-lamp-1 and cleavage with recombinant 
IgAl protease 
Prior to immunoprecipitation, cells were labelled metabolically. The 
cells were washed twice in methionine-free RPMI 1640 and incubated 
for 30 min in methionine-free medium at 37°C. Cells were adjusted to 
2X 107 cells/ml and incubated for 30 min at 37°C in methionine-free 
RPMI 1640 supplemented with 500 |lCi/ml [36S]methionine (Amer-
sham Buchler, Braunschweig, Germany). Following the pulse, cells 
were diluted 20 times with RPMI 1640 containing non-radioactive 
methionine, washed once and adjusted to 2 x l 0 6 cells/ml with 
RPMI 1640, 10%> FCS. After chase periods ranging from 0 to 240 
min, 2 ml of the suspension was pelleted and the cells were lysed in 25 
volumes of NP-40 lysis buffer (50 mM Tris-HCl, 0.15 M NaCl, 5 mM 
EDTA, 0.5% NP-40, 5 ug/ml aprotinin, 5 ug/ml leupeptin, 1 mM 
PMSF, pH adjusted to 7.5 at 4°C) on ice for 30 min. Lysates were 
centrifuged at 13000 rpm for 30 min at 4°C and the supernatants 
transferred to 1.5 ml Eppendorf reaction tubes. 80 ul monoclonal 
mouse a-h-lamp-1 (clone H4A3; IgGi) or 80 ul of an isotype matched 
control antibody (mouse a-canine E-cadherin; clone r r l ; IgGi; pro-
vided as hybridoma culture supernatant from DSHB, University of 
Iowa) was added, and samples were incubated on a rotating shaker at 
4°C for 4 h. After addition of 70 ul protein G-Sepharose (1:6 slurry of 
protein G-Sepharose and NP-40 lysis buffer) (Sigma ImmunoChemi-
cals), the samples were rotated for another 2 h at 4°C. Immunopre-
cipitates were collected by centrifugation at 4000 rpm, 3 min at 4°C 
and washed 4 times with NP-40 lysis buffer and once with PBS. 
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Precipitates were suspended in 50 ul PBS, split into two tubes and 
incubated either with or without 3 ul of recombinant gonococcal IgAl 
protease (50 ng/ul) at 37°C for 4 h. Reactions were stopped by the 
addition of 7 ill 5 X SDS sample buffer, 5% ß-mercaptoethanol and the 
proteins were resolved by SDS electrophoresis. After drying the gel, 
protein bands were detected by autoradiography or using a Phosphor-
imager (Fuji BAS Reader). 
3. Results 
3.1. Internalised N. gonorrhoeae co-localises with lysosomal 
membrane proteins 
In order to determine the intracellular life style of N. go-
norrhoeae, we set out to characterise the intracellular compart-
ment occupied by these bacteria. Using double immunofluo-
rescence staining and confocal laser scanning microscopy of 
infected cells, we were able to detect intracellular bacteria and 
eukaryotic marker proteins simultaneously. Apparently, in all 
human cell types tested, internalised gonococci co-localised 
with the lysosomal membrane proteins h-lamp-1 and h-
lamp-2. These proteins are well-known constituents of late 
endosomal/lysosomal membranes and they are also character-
istic markers for phagosomes in human professional phago-
cytes [13,20]. As can be clearly seen in Fig. 2, phagocytic 
human cells (HL60) engulfed numerous gonococci (Fig. 2A) 
and all intracellular bacteria were enclosed by h-lamp-1-pos-
itive vesicles (Fig. 2B). Additionally, although fewer bacteria 
were internalised by human epithelial cells (Chang conjuncti-
va), there was an obvious association of intracellular gono-
cocci and h-lamp-1 (Fig. 2C,D). Use of monoclonal antibod-
ies specific for h-lamp-2 resulted in the same staining pattern. 
Thus, both h-lamp proteins were present in Neisseria-contain-
ing vacuoles. 
Especially in the epithelial cells, abundant small vesicles 
marked by h-lamp were visible within the cell, but they clearly 
differed in size from the N. gonorrhoeae-contammg phago-
somes. In epithelial as well as in phagocytic cells, single dip-
lococci seemed to be enclosed by h-lamp-positive membranes. 
3.2. H-lamp-1 contains the IgAl protease cleavage consensus 
sequence 
H-lamp molecules are known to possess an IgAl globulin-
like proline/serine/threonine-rich hinge region dividing their 
intra-luminal domain into two homologous subdomains 
[8,21]. Since the cleavage sites of the IgAl protease of N. 
gonorrhoeae map within the IgAl hinge region, we compared 
the sequence of the human IgAl globulin hinge region with 
the corresponding sequences of h-lamp molecules (Fig. 1). 
Studies on the processing of IgAl as well as the IgAl protease 
precursor led to a consensus sequence for cleavage by the 
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Fig. 1. Amino acid sequence comparison of the hinge-like regions of 
human lysosome-associated membrane proteins and the hinge region 
of human IgAl globulin. The potential cleavage sites of the IgAl 
protease of N. gonorrhoeae MS11 (PPXP, where X can represent 
alanine, threonine, or serine) are marked by an arrow ( J. ). The ami-
no acid sequences are derived from Fukuda et al. [8] (h-lamp-1 and 
h-lamp-2) and Liu et al. [9] (IgAl globulin), and the amino acids 
are numbered according to their position in the mature protein. 
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Fig. 2. Internalised N. gonorrhoeae co-localise with human lysosome-associated membrane proteins. Human phagocytic HL60 cells (A, B) and 
Chang conjunctiva cells (C, D) were infected with gonococci for 2 h or 4 h, fixed with paraformaldehyde and stained simultaneously with a 
polyclonal rabbit a-N. gonorrhoeae serum (A, C) and a monoclonal mouse a-h-lamp-1 antibody (B, D). Confocal laser scanning microscopy re-
vealed that intracellular bacteria (arrowheads; A, C) are tightly surrounded by h-lamp-1-coated membranes (arrowheads; B, D). The bars rep-
resent 5 (xm. 
gonococcal enzyme [2,10]. Interestingly, h-lamp-1 contains 
two sites fulfilling the requirements for cleavage by the IgAl 
protease of N. gonorrhoeae within its luminal proline-rich se-
quence (Fig. 1). Intracellular bacteria are therefore in close 
contact with the hinge-like region of h-lamp-1, where target 
sites of the secreted bacterial protease are located. 
3.3. The IgAl protease is active in a low pH environment 
To exert its action on h-lamp-1 the IgAl protease has to be 
active under conditions described for late endosomal/lysoso-
mal compartments. The most prominent characteristic of such 
vesicles is their low pH. During phagosome maturation the 
pH drops from the pH of the extracellular milieu down to pH 
4.5-5 [20,22]. Therefore, an intra-phagosomally active pro-
tease has to be pH tolerant. Since this has not previously 
been assessed for neisserial IgAl protease, the purified enzyme 
was incubated with its cognate substrate human IgA globulins 
under varying pH conditions. Both at neutral and at low pH, 
i.e. pH 4.5, the typical cleavage products of the IgAl globulin 
heavy chain were readily produced (Fig. 3). Compared to 
neutral pH conditions, there was no gross difference in the 
reactivity of the enzyme detectable. Intact IgA heavy chains 
visible on the gel after protease treatment reflected the pres-
ence of IgA2 molecules in the IgA preparation derived from 
human sputum. 
3.4. The IgAl protease cleaves h-lamp-1 from epithelial 
cell lines 
In order to demonstrate that the neisserial protease is in-
deed capable of cleaving human lysosome-associated mem-
brane proteins, we immunoprecipitated h-lamp-1 of 
[35S]methionine-labelled cells and incubated the precipitate 
with purified gonococcal IgAl protease. Since lamp proteins 
are post-translationally modified, we first determined the ma-
turation kinetics of these glycosylated proteins in the different 
cell lines used. As is shown for myelomonocytic JOSK-M cells 
in Fig. 4A, newly synthesised lamp-1 matured from a 80-95 
kDa form to a larger ~ 150 kDa form within 4 h. This is in 
accordance with the kinetics found for the transport of newly 
synthesised lysosomal lamps in mouse macrophages and nor-
Fig. 3. The gonococcal IgAl protease is active in a low pH environ-
ment. Human IgAl molecules (2 |xg) were incubated with recombi-
nant IgAl protease of N. gonorrhoeae (50 ng/u.1) or mock-incubated 
for 3 h at 37°C in buffers adjusted to different pH as indicated at 
the top of each lane. Samples were subsequently analysed by SDS-
PAGE and protein bands were visualised by silver staining. Cleaved 
fragments of the IgAl globulin heavy chain (arrowhead) can be 
seen in all the preparations where IgAl protease has been added. 
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Fig. 4. N. gonorrhoeae IgAl protease cleaves h-lamp-1 isolated from human epithelial cells in vitro. A: Human myelomonocytic JOSK-M cells 
were metabolically labelled with [35S]methionine for 30 min and h-lamp-1 was immunoprecipitated with a-h-lamp-1 monoclonal antibodies 
(H4A3) after different chase periods as indicated. Immunoprecipitates were analysed by SDS-PAGE and visualised using a Phosphorlmager. 4 h 
after the pulse, all labelled h-lamp-1 was found to be in the highly glycosylated mature form (*). B: H-lamp-1 (*) immunoprecipitated from 
human myelomonocytic JOSK-M cells and human myelocytic HL60 cells was incubated with recombinant gonococcal IgAl protease or buffer 
for 4 h at 37°C as indicated. Fragments of the expected size (bar) were detectable neither by SDS PAGE nor by autoradiography. C: H-lamp-
1 (*) immunoprecipitated with a-h-lamp-1 monoclonal antibodies (H4A3) from metabolically labelled Chang epithelial cells and RT112 cells 
was incubated for 4 h at 37°C with recombinant gonococcal IgAl protease or buffer as indicated. Incubation with the protease results in degra-
dation of h-lamp-1 into fragments of about 60-80 kDa (bar). 
mal rat kidney epithelioid cells [23]. Consequently, in subse-
quent experiments, cells were lysed to carry out immunopre-
cipitations 4 h after the [35S]methionine pulse, in order to have 
the mature glycosylated forms of the proteins labelled. When 
the h-lamp-1 protein was isolated in this way from phagocytic 
human cells (JOSK-M, HL60) a protein of ~ 150 kDa was 
detected. The immunoprecipitated lamp appeared as a broad 
band after SDS-PAGE as previously reported [24,25]. No 
such band was visible in the control samples, where an iso-
type-matched antibody was used for precipitation. The iso-
lated h-lamp-1 of phagocytic human cells was then incubated 
with recombinant IgAl protease but cleavage products were 
not detectable (Fig. 4B). 
Lamp-1 proteins immunoprecipitated from human epithe-
lial cells (Chang, RT112) showed a different migration on 
SDS gels (Fig. 4C). It is known that different cell lines pro-
duce h-lamp glycoproteins of different apparent molecular 
weight, which is most likely due to differential glycosylation 
[25]. It appeared in our experiments that h-lamp proteins from 
epithelial cells were less glycosylated (size ~ 115 kDa) as com-
pared with the forms in phagocytic cells. Interestingly, when 
we incubated h-lamp-1 isolated from different human epithe-
lial cell lines with the neisserial IgAl protease, the immuno-
precipitated band of about 115 kDa vanished and cleavage 
products in the range of 60-80 kDa appeared (Fig. 4C). The 
size of the cleavage products was consistent with the idea that 
the IgAl protease cleaved within the hinge-like region located 
on the luminal side of h-lamp-1. 
3.5. Enhanced survival of IgAl protease-expressing gonococci 
in epithelial cells? 
To test whether the ability of the IgAl protease to cleave 
phagosomal h-lamp-1 molecules could promote the intracellu-
lar accommodation and survival of N. gonorrhoeae, we inves-
tigated the survival of isogenic IgAl protease mutants in 
Chang conjunctiva epithelial cells, a well-characterised in vitro 
infection model [17,26], and RT112 bladder carcinoma cells 
[16]. For this purpose, we infected the cells with N. gonor-
rhoeae N303 (Opa50
+, IgAl protease+) or with N876 (Opa50
+, 
IgAl protease") at a bacteriaxell ratio of 30:1 for 6 h 
(Chang) or 12 h (RT112), respectively. After washing and 
an additional 1 h treatment with 50 u.g/ml gentamicin, the 
cells were lysed with 1% saponin and suitable dilutions of 
the recovered bacteria were plated out. In none of these ex-
periments were we able to reveal significant differences in the 
survival of IgAl protease-positive versus IgAl protease-neg-
ative gonococci (data not shown). 
4. Discussion 
Lysosome-associated membrane proteins (lamps) are 
known from several vertebrate species. Two distinct mole-
cules, h-lamp-1 and h-lamp-2, have been characterised and 
sequenced in humans [8,25]. They are highly homologous to 
membrane proteins isolated from mouse, rat and chicken 
[27,28]. The major characteristic is their high content of N-
linked glycans, some of which are polylactosaminoglycans 
[25]. Whereas the polypeptide core of lamps accounts for 
about 40 kDa, the mature proteins have an apparent molec-
ular weight > 100 kDa. Though lamp proteins seem to be 
conserved during evolution, their function is still unclear. It 
is speculated that they protect the membrane from the action 
of degradative enzymes within the lysosome by forming a 
carbohydrate coat on the luminal face of the lysosomal mem-
brane [27,28]. 
From several studies it has emerged that lamps are not only 
found in mature lysosomes but that they are characteristic 
constituents of phagosomal membranes [20,22]. Inert particles 
as well as live bacteria are found within lamp-positive vesicles 
shortly after their uptake by professional and non-professio-
nal phagocytes [13,20]. We show here that also N. gonorrhoeae 
co-localises with h-lamp proteins once inside epithelial or 
phagocytic cells (Fig. 2). As can be seen by immunofluores-
cence staining of infected cells, there is a tight association of 
the vesicle membrane and the enclosed gonococci. Given the 
small volume of the Neisseria-cont&mmg phagosome, proteins 
secreted by internalised gonococci should accumulate at rela-
tively high concentrations. One of the best characterised se-
creted products of the pathogenic Neisseriae is the IgAl pro-
tease, which is secreted via an autotransporter mechanism [2]. 
The enzyme seems to be expressed constitutively by N. gonor-
rhoeae MS11, but only at low levels [29]. In addition, our 
results demonstrate that the protease activity is not affected 
by low pH conditions. We therefore believe that the enzyme is 
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expressed by internalised N. gonorrhoeae and that it is able to 
exert its activity in a maturing phagosome even at a non-
physiologic pH. Since the lysosomal membrane protein fa-
lamp-1 is an abundant constituent of the phagosomal mem-
brane and since it contains the IgAl protease cleavage site 
consensus, we investigated if this protein could be a substrate 
of the neisserial enzyme. Our results demonstrate that the 
mature glycosylated form of h-lamp-1 derived from epithelial 
cells is susceptible to degradation by IgAl protease. In addi-
tion, our data argue that in vitro the extent of glycosylation of 
the h-lamp-1 protein defines its sensitivity against degradation 
by the bacterial enzyme. Less glycosylated h-lamp-1 isolated 
from epithelial cells was readily degraded by IgAl protease 
whereas the larger forms isolated from professional phago-
cytes were resistant against the activity of the enzyme. It is 
intriguing to speculate that in a rally of arms the pressure by 
pathogens and their secreted proteases has driven the evolu-
tion towards higher glycosylation and in this way towards 
more resistant h-lamp proteins in phagocytic cells. 
Pathogenic Neisseria are known to interact with different 
cell types during the course of an infection [1]. Especially their 
attachment to and invasion of epithelial cells has been studied 
in great detail [17,18]. In addition, electron microscopic inves-
tigations have provided insights into the intracellular com-
partment inhabited by gonococci in epithelial cell lines and 
primary human cells [26,30]. Though in most cases the bac-
teria were found to reside in membrane-enclosed vesicles, sev-
eral studies suggest an occasional escape of gonococci from 
the phagosome into the cytoplasm of epithelial cells ([30], 
Mosleh et al., submitted). Intracytosolic bacteria have been 
more often detected in human primary epithelial cells than 
in the standard infection models using permanent cell lines. 
It is therefore possible that phagosomal escape in native mu-
cosal tissues is a natural event, and that IgAl protease may 
facilitate the destruction of the phagosomal membrane. 
We were not able to show a difference in the capability of 
wild-type and IgAl protease-deficient N. gonorrhoeae MS11 
to survive within Chang epithelial cells or RT112 using gen-
tamicin assays (data not shown). This result is in contrast with 
a preliminary report suggesting that IgAl protease is essential 
for the survival within epithelial cells [31]. Whether the differ-
ence of our result is due to the failure of this system to detect 
minute disparities in intracellular survival or to inherent dif-
ferences between permanent epithelial cell lines and primary 
urethral or cervical cells must be the subject of future studies. 
For instance, the ratio of h-lamp-1 versus h-lamp-2 in the 
/Ve/ssena-containing vacuole could determine the ability of 
gonococci to escape this compartment and this ratio could 
be different in primary and permanent cells. Given the possi-
ble new role for the gonococcal protease in the interaction 
with the human host, it seems interesting now to investigate 
if IgAl proteases derived from other species like N. meningi-
tidis or Haemophilus influenzae [4,32], Streptococcus pneumo-
niae [33] or IgAl protease homologues with no reported func-
tion from other pathogenic microorganisms like SepA of 
Shigella flexneri [34] have the potential to interfere with hu-
man lysosomal/phagosomal membrane proteins, too. 
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